What Patients are Eligible for Pre-Approval Drug Access? Recently approved legislation, the 'Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017', allows patients in the US the ability to [...]
Why Collect Real-World Data (RWD) Randomized controlled trials (RCTs) have long served as the gold standard for developing and assessing new drugs and devices. However, over the past couple of years, there has been a [...]
WEP CLINICAL PARTNERS WITH SOLASIA PHARMA K.K. TO LAUNCH DARVIAS NAMED PATIENT PROGRAM Morrisville, NC, USA & London, UK – March 20, 2023 – WEP Clinical LTD (WEP), a specialist services company that works with drug [...]
WEP CLINICAL PARTNERS WITH Y-MABS THERAPEUTICS TO PROVIDE DANYELZA THROUGH A NAMED PATIENT ACCESS PROGRAM IN EUROPE Morrisville, NC, USA & London, UK – February 16, 2023 – WEP Clinical (WEP) is pleased to announce [...]
WEP CLINICAL HAS PARTNERED WITH TAIMED BIOLOGICS TO LAUNCH A TROGARZO NAMED PATIENT PROGRAM Morrisville, NC, USA & London, UK – February 6, 2023 – WEP Clinical LTD (WEP), a specialist services company that works with [...]
Three Things Patients Should Know About Companies Providing Expanded Access Use of their Investigational Drugs Expanded Access Programs (EAPs), also referred to as Managed Access or Compassionate Use Programs, allow patients with no viable treatment [...]
Key Expanded Access Strategies All Companies Should Adopt Recent conversation regarding expanded access has focused heavily on the necessity of the FDA approval process. Right to Try legislation, which would remove the FDA from the [...]
Many proponents of Right to Try legislation believe that the US Food and Drug Administration (FDA) is too slow and inefficient when it comes to reviewing requests for access to important investigational new drugs. They, [...]
Upcoming US legislation, known as the 21st Century Cures Act, will incorporate more of the patient experience into drug development. There will be a focus on structured collection of data from patients about the personal [...]
Expanded Access Programs (EAPs), also known as Managed Access Programs, help sick patients gain access to drugs that are not available through traditional access routes. These can be drugs that are still in development, in [...]
